Dr. Ben Ebert, President and CEO of Dana-Farber Cancer Institute
The Walker Webcast
00:00
Advancements in Cancer Detection and AI Integration
This chapter discusses the critical role of early detection tests, such as blood biopsies and traditional screening methods like mammograms, in reducing cancer mortality rates. It highlights the transformative impact of artificial intelligence in cancer research, including breakthroughs like AlphaFold, which aids in drug discovery and improving diagnostic accuracy. The conversation also explores the optimism surrounding advancements in targeting challenging cancer proteins and the potential future improvements in treatment outcomes.
Transcript
Play full episode
